Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 December 2022 | Story Rulanzen Martin | Photo Barend Nagel
From the left: Rulanzen Martin, Lacea Loader, Dr Nitha Ramnath, and Martie Nortjé.

Another year, another round of national and international awards for the Department of Communication and Marketing’s (DCM) campaigns and projects. This year saw DCM pick up an International Association of Business Communicators (IABC) Africa Silver Quill Award of Excellence for Communication Research for Narrative Building Storytelling. This project and subsequent award were in partnership with Development Communication Solutions (DevCom), led by Lacea Loader, Director: Communication and Marketing. 

During the 2022 annual Marketing, Advancement and Communication in Education (MACE) Excellence Awards, DCM won four excellence awards. Dr Nitha Ramnath, Deputy Director: Corporate Relations, won a Silver Award of Excellence for the 2021 Rector’s Concert, and a Bronze Award of Excellence for the 2022 Rector’s Concert. 

Lacea Loader and Martie Nortjé, Manager: Reputation, Brand and Marketing Management, won a Bronze Award of Excellence for the project ‘UFS – Our Story: The building and implementation of a brand narrative.’ Rounding up the UFS’ winning tally was Website Editor, Rulanzen Martin, who won a MACE Bronze Award of Excellence for the 2021 UFS Deaf Awareness Month (DAM) Campaign. The DAM campaign also received recognition during the 2021 IABC Silver Quill awards, where it won a Silver Quill Award of Excellence. 

Awards a perfect opportunity to benchmark 

“The awards give recognition to the communication efforts and endeavours undertaken by DCM as the strategic communication partner at the UFS; it also serves as a perfect opportunity to benchmark against peers and the industry. I am extremely proud of what the team has achieved,” says Loader.  “It is an honour when our projects receive awards, given the calibre of entries submitted for both the IABC and MACE awards programmes. The IABC awards programme is for all industries, while the MACE awards only recognise higher education institutions,” she says. 

For the 2022 MACE Excellence Awards, a total of 95 awards were awarded to 12 institutions from a total of 171 entries.

News Archive

UFS researcher explores the future cost of cancer
2017-01-10

 Description: 001 Dr Alicia Sherriff Tags: 001 Dr Alicia Sherriff

Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.

Photo: Charl Devenish

Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.

Cancer is on the rise

There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.

The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.

Adoption of new strategies

According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.

Efficient solutions to curb cancer mortality

The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept